$INVA 3 SEC Filings

Filed On	Filing
20 May 2026	Form 3: Linden Josephine, Director Holds 0 shares of No securities beneficially owned
01 May 2024	Form 3: Small Derek A, Director
10 Jan 2024	Form 3: Ronsheim Matthew, See Remarks Holds 12,945 shares of Common Stock
31 Aug 2023	Form 3: Basso Stephen, Chief Financial Officer No securities owned
02 Aug 2023	Form 3: Koziel Margaret, Chief Medical Officer No securities owned
15 May 2023	Form 3: Denner Alexander J, 10% owner and 1 other Holds 6,614,000 shares of Common Stock, par value $0.01 per share
06 Jan 2023	Form 3: Srivastava Sapna, Director
26 Aug 2022	Form 3: Edwards Larry G., CEO of La Jolla Pharmaceutical No securities owned
16 Mar 2021	Form 3: Birx Deborah, Director Holds 0 shares of No securities beneficially owned
29 May 2020	Form 3: Raifeld Pavel, Chief Executive Officer
23 Apr 2020	Form 3: Innoviva, Inc., 10% owner · Entasis Therapeutics Holdings Inc. Holds 1,322,510 shares of Common Stock
14 Feb 2020	Form 3: Innoviva, Inc., 10% owner · Armata Pharmaceuticals, Inc. Holds 993,139 shares of Common Stock
13 Aug 2018	Form 3: Zhen Marianne, Chief Accounting Officer Holds 24,104 shares of Common Stock
22 May 2018	Form 3: Hulme Geoffrey, interim PEO Holds 3,500 shares of Common Stock
14 Feb 2018	Form 3: Haimovitz Jules, Director Holds 12,200 shares of Common Stock
14 Feb 2018	Form 3: Schlesinger Sarah J., Director No securities owned
14 Feb 2018	Form 3: DiPaolo Mark, Director No securities owned
21 Dec 2017	Form 3: Kostas Odysseas D, Director Holds 0 shares of No securities are beneficially owned.
21 Dec 2017	Form 3: Bickerstaff George, Director Holds 0 shares of No securities are beneficially owned.
21 Nov 2016	Form 3: Duncan Barbara Gayle, Director Holds 0 shares of No securities are beneficially owned.

Comments